Jason Myers

Jason Myers has a diverse work experience in the biosciences and healthcare industries. Jason has held various roles such as Co-Founder at the UPSWING Foundation, where they focused on providing equal opportunities in sports and education. Jason also served as a Member of the Board of Directors at TwinStrand Biosciences, InterVenn Biosciences, G2G Ventures, Sequencing Health, IsoPlexis, Genapsys, and Invitae. In these positions, they played a key role in strategic decision-making and governance. Additionally, Jason served as the Chief Executive Officer at Sequencing Health, Genapsys, and was previously the President of Oncology at Invitae. Notably, they served as the Chief Executive Officer of ArcherDX, leading the company's development of products for cancer care before its acquisition by Invitae. Jason has a strong background in genomics, molecular biology, and healthcare innovation.

Jason Myers earned a PhD in Molecular Pharmacology from Stanford University School of Medicine from 1999 to 2005. Prior to that, they completed their Bachelor of Applied Science (BASc) in Biochemistry and Molecular Biology from Colorado State University from 1993 to 1997.